Article: Study aims to reduce risk of asthma by treating infant atopic dermatitis

Researchers hope aggressive therapy may alter future course of skin disorder

National report - A large, prospective, six-year clinical trial is well under way to investigate whether early, aggressive treatment of atopic dermatitis in infants can alter the future course of their skin disorder and the development of other manifestations of atopy, particularly asthma.

The study, launched last fall, is enrolling approximately 1,100 children ages 3 months to 18 months with a <3-month duration of atopic dermatitis and an immediate family member with atopic disease. The children are being randomized to initial double-blind treatment of active atopic dermatitis with pimecrolimus cream 1 percent ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!